Jennifer Friel GoldsteinManaging Partner, Life Science and Healthcare at SVB Capital
Jennifer Friel Goldstein, Head of Business Development, Technology and Healthcare. Jennifer is responsible for Business Development, Venture Capital, and Corporate Relationships across all sectors for the bank, helping drive growth throughout the innovation ecosystem. Jennifer has initiated the creation of a Healthcare equity fund and was directly involved with the company’s acquisition of Leerink Partners. Jennifer has held several important roles at SVB, including running the Biotechnology practice, leading West Coast Healthcare, starting our Healthcare Accelerator, and managing our Strategic Advisory Services practice. Jennifer joined SVB after a successful tenure on Pfizer’s Venture Capital team. While a consultant at Bain, Jennifer focused on private equity. She also served in technical roles at Chiron, Genelabs, and Genencor. Jennifer brings 20 years of investing, banking, business development, and strategy experience to the team. She graduated magna cum laude with a BSE in Bioengineering and a Master's of Biotechnology from the University of Pennsylvania and was named a Joseph Wharton Fellow while completing her MBA at the Wharton School. In her free time, Jennifer enjoys supporting SpringBoard Enterprises, serving on the board of the Leukemia and Lymphoma Society, and spending time with her husband and their twin children.